当前位置:首页 - 行情中心 - 兰卫医学(301060) - 财务分析 - 现金流量表

兰卫医学

(301060)

  

流通市值:37.28亿  总市值:41.45亿
流通股本:3.60亿   总股本:4.01亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,203,495,752.18781,733,754.17401,580,869.232,071,076,712.39
  收到的税费返还---5,871,422.87
  收到其他与经营活动有关的现金20,557,668.0612,249,793.745,032,851.8741,976,547.42
  经营活动现金流入小计1,224,053,420.24793,983,547.91406,613,721.12,118,924,682.68
  购买商品、接受劳务支付的现金719,708,529.91527,988,600.72289,296,873.441,449,557,377.1
  支付给职工以及为职工支付的现金196,678,257.82135,944,398.6270,124,452.22273,902,848.55
  支付的各项税费38,582,955.3428,103,565.359,937,391.7254,301,614.49
  支付其他与经营活动有关的现金97,324,785.8264,712,886.1835,596,870.71124,850,026.36
  经营活动现金流出小计1,052,294,528.89756,749,450.87404,955,588.091,902,611,866.5
  经营活动产生的现金流量净额171,758,891.3537,234,097.041,658,133.01216,312,816.18
二、投资活动产生的现金流量:
  收回投资收到的现金1,194,930,000748,100,000254,800,000230,000,000
  取得投资收益收到的现金2,851,854.991,596,141.54379,614.39630,098.63
  处置固定资产、无形资产和其他长期资产收回的现金净额3,312,4702,036,417.98725,6915,601,966.35
  处置子公司及其他营业单位收到的现金净额3,331,5003,331,500131,5003,802,130.7
  投资活动现金流入小计1,204,425,824.99755,064,059.52256,036,805.39240,034,195.68
  购建固定资产、无形资产和其他长期资产支付的现金36,112,830.5622,704,958.511,872,288.1576,615,801.84
  投资支付的现金1,194,930,000748,100,000309,700,000232,000,000
  投资活动现金流出小计1,231,042,830.56770,804,958.5321,572,288.15308,615,801.84
  投资活动产生的现金流量净额-26,617,005.57-15,740,898.98-65,535,482.76-68,581,606.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金---3,560,000
  其中:子公司吸收少数股东投资收到的现金---3,560,000
  取得借款收到的现金50,000,00050,000,000-122,930,000
  收到其他与筹资活动有关的现金100,000---
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计50,100,00050,000,000-126,490,000
  偿还债务支付的现金110,000,00092,500,0007,500,000221,716,000
  分配股利、利润或偿付利息支付的现金157,917,270.7990,028,798.248,787,262.5157,906,726.36
  其中:子公司支付给少数股东的股利、利润73,800,000--50,550,000
  支付其他与筹资活动有关的现金9,790,147.317,419,098.523,421,266.7827,121,761.67
  筹资活动现金流出小计277,707,418.1189,947,896.7619,708,529.29306,744,488.03
  筹资活动产生的现金流量净额-227,607,418.1-139,947,896.76-19,708,529.29-180,254,488.03
四、汇率变动对现金及现金等价物的影响-27,346.41-22,973.6-22,811.22-
五、现金及现金等价物净增加额-82,492,878.73-118,477,672.3-83,608,690.26-32,523,278.01
  加:期初现金及现金等价物余额825,747,324.57825,747,324.57825,747,324.57858,270,602.58
  期末现金及现金等价物余额743,254,445.84707,269,652.27742,138,634.31825,747,324.57
补充资料:
  净利润--3,806,701.02--98,590,178.09
  资产减值准备-18,669,341.3-103,406,254.98
  固定资产和投资性房地产折旧-29,287,708.23-58,732,375.93
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,287,708.23-58,732,375.93
  无形资产摊销-2,508,922.77-5,595,013.27
  长期待摊费用摊销-7,129,829.73-25,642,978.2
  处置固定资产、无形资产和其他长期资产的损失-31,336.55--5,877,665.59
  固定资产报废损失-547,565.46-2,128,981.97
  公允价值变动损失--51,715.73--
  财务费用-3,608,251.42-10,808,964.34
  投资损失-1,822,039.79--892,029.82
  递延所得税--170,346.64--24,870,207.04
  其中:递延所得税资产减少-753,158.36--25,318,056.85
    递延所得税负债增加--923,505-447,849.81
  存货的减少--28,907,838.33-9,431,562.18
  经营性应收项目的减少--28,278,756.52-218,805,727.34
  经营性应付项目的增加-28,045,934.91--121,582,827.52
  其他-799,587.53-19,932,470.39
  现金的期末余额-707,269,652.27-825,747,324.57
  减:现金的期初余额-825,747,324.57-858,270,602.58
  现金及现金等价物的净增加额--118,477,672.3--32,523,278.01
公告日期2025-10-282025-08-262025-04-282025-04-28
审计意见(境内)标准无保留意见
TOP↑